β-Carotene down-regulates inducible nitric oxide synthase gene expression and induces apoptosis by suppressing bcl-2 expression and activating caspase-3 and p53 genes in B16F-10 melanoma cells

Nutrition Research

Volumn 27, Issue 6, 2007, Pages 336-342

  Guruvayoorappan, Chandrasekharan ^a   Kuttan, Girija ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Carotene; Apoptosis; B16F 10 melanoma cells; bcl 2; Caspase 3; iNOS

Indexed keywords

BETA CAROTENE; CASPASE 3; DNA FRAGMENT; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME REPRESSION; GENE EXPRESSION REGULATION; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 34250771619     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.04.009     Document Type: Article

References (46)

1. Gerster H. β-Carotene, vitamin E and vitamin C in different stages of experimental carcinogenesis. Eur J Clin Nutr 49 (1995) 155-168
2. Mayne S.T. β-Carotene, carotenoids, and disease prevention in humans. FASEB J 10 (1996) 690-701
3. Clinton S.K. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 56 (1998) 35-51
4. Paollini M., Abdel-Rahman S.Z., Sapone A., Pedull G.F., Perocco P., Cantelli-Forti G., et al. Beta-carotene: a cancer chemopreventive agent or co-carcinogen?. Mutat Res 543 (2003) 195-200
5. Burton G.W., and Ingold K.U. β-Carotene: An unusual type of lipid antioxidant. Science 224 (1984) 569-573
6. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine. 3rd ed. (1999), Oxford University Press, New York, NY 223-225
7. Pradeep C.R., and Kuttan G. Effect of beta-carotene on the inhibition of lung metastasis in mice. Phytomedicine 10 (2003) 159-164
8. Wyllie A.H., Kerr J.F., and Currie A.R. Cell death: the significance of apoptosis. Int Rev Cytol 68 (1980) 251-306
9. Ramp U., Caliskan E., Mahotka C., Krieg A., Heikaus S., Gabbert H.E., et al. Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage. Br J Cancer 88 11 (2003) 1800-1807
10. Jimbo A., Fujita E., Kouroku Y., Ohnishi J., Inohara N., Kuida K., et al. ER stress induces caspase-8 activation, stimulating cytochrome C release and caspase-9 activation. Exp Cell Res 283 2 (2003) 156-166
11. Yi X., Yin X.M., and Dong Z. Inhibition of Bid-induced apoptosis by Bcl-2. tBid insertion, Bax translocation and Bax/Bak oligomerization suppressed. J Biol Chem 278 19 (2003) 16992-16999
12. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 3 (1997) 323-331
13. Altucci L., and Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 1 (2001) 181-193
14. Palozza P., Serini S., Torsello A., Boninsegna A., Covacci V., Maggiano M., et al. Regulation of cell cycle progression and apoptosis by β-carotene in undifferentiated and differentiated HL-60 leukemia cells: possible involvement of a redox mechanism. Int J Cancer 97 (2002) 593-600
15. Green L.C., Wagner D.A., Glogowiski J., Skipper P.L., Wishnok J.S., and Tannenbaum S.R. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Anal Biochem 126 1 (1982) 131-138
16. Sugarman B.J., Agarwal B.B., Hass P.E., Figari I.S., Palladino M.A., and Shepard H.M. Recombinant human tumour necrosis factor-alpha: effects on proliferation on normal and transformed cells in vitro. Science 230 4728 (1985) 943-945
17. Tomkins P., Cooper K., Webber D., and Bower G. The L929 cell bioassay for murine tumour necrosis factor is not influenced by other cytokines. J Immunol Methods 151 1-2 (1992) 313-315
18. Evan G., and Littlewood T. A matter of life and cell death. Science 281 5381 (1998) 1317-1322
19. Mayne S.T. β-Carotene, carotenoids and disease prevention in humans. FASEB J 10 7 (1996) 690-701
20. Kojima M., Morisaki T., Tsukahara Y., Uchiyama A., Matsunari Y., Mibu R., et al. Nitric oxide synthase expression and nitric oxide production in human colon carcinoma tissue. J Surg Oncol 70 4 (1999) 222-229
21. Tschugguel W., Pustelnik T., Lass H., Mildner M., Weninger W., Schneeberger C., et al. Inducible nitric oxide synthase (iNOS) expression may predict distant metastasis in human melanoma. Br J Cancer 79 9-10 (1999) 1609-1612
22. Thomsen L.L., Lawton F.G., Knowles R.G., Beesley J.E., Riveros-Moreno V., and Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54 5 (1994) 1352-1354
23. Tanaka H., Kijima H., Tokunga T., Tajima T., Himeno S., Kenmochi T., et al. Frequent expression of inducible nitric oxide synthase in esophageal squamous cell carcinomas. Int J Oncol 14 6 (1999) 1069-1073
24. Tschugguel W., Schneeberger C., Unfried G., Czerwenka K., Weninger W., Mildner M., et al. Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res Treat 56 2 (1999) 145-151
25. Gallo O., Masini E., Morbidelli L., et al. Role of nitric oxide in angiogenesis and tumour progression in head and neck cancer. J Natl Cancer Inst 90 8 (1998) 587-596
26. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumour angiogenesis and colon cancer progression. Cancer Res 58 2 (1998) 334-341
27. Gelin J., Moldawer L.L., Lonnroth C., Sherry B., Chizzonite R., and Lundhilm K. Role of endogeneous tumour necrosis factor α and interleukin 1 for experimental tumour growth and the development of cancer cachexia. Cancer Res 51 1 (1991) 415-421
28. Wu S., Boyer C.M., Whitacker R.S., Berchuck A., Weiner J.R., and Weinberg J.B. Tumour necrosis factor α as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumour cell proliferation and tumour necrosis factor α expression. Cancer Res 53 8 (1993) 1939-1944
29. Orosz P., Echtenacher B., Falk W., Ruschoff J., Weber D., and Mannel D.N. Enhancement of experimental metastasis by tumour necrosis factor. J Exp Med 177 5 (1993) 1391-1398
30. Suganuma M., Okabe S., Sueoka E., Iida N., Komori A., Kim S.J., et al. A new process of cancer prevention mediated through inhibition of tumour necrosis factor α expression. Cancer Res 56 16 (1996) 3711-3715
31. Manchester K.M., Heston W.D., and Donner D.B. Tumour necrosis factor-induced cytotoxicity is accompanied by intracellular mitogenic signals in ME-180 human cervical carcinoma cells. Biochem J 290 (1993) 185-190
32. Matthews N., Neale M.L., Jackson S.K., and Stark J.M. Tumour cell killing by tumour necrosis factor: inhibition by anaerobic condition, free radical scavengers and inhibitors of arachidonate metabolism. Immunology 62 1 (1987) 153-155
33. Schwartz S.A., Hemandez A., and Mark Evans B. The role of NF-kappa B/I kappa B proteins in cancer: implications for novel treatment strategies. Surg Oncol 8 3 (1999) 143-153
34. Bours V., Bentires-Ali M., Hellin A., Viatour P., Robe P., Delhalle S., et al. Nuclear factor-kappa B, cancer and apoposis. Biochem Pharmacol 60 8 (2000) 1085-1090
35. Hong Y.S., Ham Y.A., Choi J.H., and Kim J. Effects of allyl sulfur compounds and garlic extract on the expression of Bcl-2, Bax and p53 in non small cell lung cancer cell lines. Exp Mol Med 32 3 (2000) 127-134
36. Kuo M.L., Huang T.S., and Lin J.K. Curcumin, an antioxidant and antitumour promoter induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317 2 (1996) 95-100
37. Okura T., Igase M., Kitami Y., Fukuoka T., Maguchi M., Kohara K., et al. Platelet derived growth factor induces apoptosis in vascular smooth muscle cells: roles of the Bcl-2 family. Biochim Biophys Acta 1403 3 (1998) 245-253
38. Tseng T.H., Kuo T.W., Chu C.Y., Chou F.P., Lin W.L., and Wang C.L. Induction of apoptosis by hibiscus protocatechuic acid in human leukemia cells via reduction of retinoblastoma (RB) phosphorylation and Bcl-2 expression. Biochem Pharmacol 60 3 (2000) 307-315
39. el-Deiry W.S., Kem S.E., Pietenpol J.A., Kinzler K.W., and Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1 1 (1992) 45-49
40. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75 4 (1993) 817-825
41. Miyashita T., and Reed J.C. Tumour suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 2 (1995) 293-299
42. Sandri M.I., Issacs R.J., Ongkeko W.M., Harris A.L., Hickson I.D., Broggini M., et al. p53 regulates the minimal promoter of the human topoisomerase II alpha gene. Nucleic Acids Res 24 (1996) 4464-4470
43. Momand J., Zambetti G.P., Olson D.C., George D., and Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69 7 (1992) 1237-1245
44. Caspari T. How to activate p53. Curr Biol 10 8 (2000) R315-R317
45. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
46. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., and Earnshaw W.C. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371 6495 (1994) 346-347